About Aaron

Social

Read Chapter 1
The classic chest-crushing heart attack presentation appears in only 30% of women. Women’s symptoms differ from men’s in 95% of cases. Women under 55 are twice as likely to die after a heart attack compared to men the same age. 80% of cardiac research participants are men — so emergency protocols and diagnostic criteria were built around male presentation patterns.

#MedicalBlindSpots #WomensHealth #HeartAttack #MedicalFeminism
You were told to stretch because you look flexible.

Here is why that backfires.

Bone pain in hypermobility is often small micro-tears. The stretchiness causes the tear. The tear causes inflammation. The inflammation causes the pain.

So tissue that already travels farther than it should does not need help traveling farther. Passive stretching asks tissue you can’t yet control to lengthen, which adds to the tearing that was generating the pain in the first place.

That is one of two pieces of standard advice that make hypermobility worse. The other one has a number attached to it, and it’s the one nobody gets told.

Comment READ and I’ll send you the full article.

#hypermobility #hEDS #EDS #hypermobilityspectrumdisorder #chronicpain #chronicillness #functionalmedicine #pacing #POTS #connectivetissue #stretching #jointpain
Heart disease is the number one killer of women, yet 80% of cardiovascular research subjects are men. Women are 50% more likely to receive a wrong initial diagnosis for a heart attack. Women’s hearts are structurally different — different size, ejection fraction, and failure pattern — and this wasn’t formally studied until the 1990s. Research-to-practice translation takes 30–50 years, meaning current cardiology protocols are still largely built around male physiology.

#MedicalBlindSpots #WomensHealth #HeartDisease #MedicalFeminism
Women have different body fat distribution, muscle mass, hormonal cycling, and immune system profiles than men — all of which affect how medications work. These differences were recognized in basic science but deliberately set aside in evidence-based research trials. Women are 50–75% more likely to experience adverse drug reactions as a result. Neuroendocrine disruptors in the environment also disproportionately affect women’s fertility and hormonal regulation in ways that remain poorly studied.

#MedicalBlindSpots #WomensHealth #MedicalFeminism #DrugSafety
Ambien is twice as potent in women as in men because of differences in body fat percentage, muscle mass, and hormone metabolism. It took the FDA over two decades to recognize this and cut the recommended dose for women in half. Women are 50–75% more likely to experience adverse drug reactions than men — a direct consequence of excluding women from pre-market drug trials. Water-soluble and fat-soluble medications behave fundamentally differently in women’s bodies.

#MedicalBlindSpots #WomensHealth #DrugReactions #MedicalFeminism
In 1993, the NIH Revitalization Act required the inclusion of women in federally funded clinical research. Before that, women — particularly those of childbearing age — were excluded from phase 1 and phase 2 trials because hormonal complexity made research harder. The drugs were tested on men and prescribed to women regardless. Women are now known to be 50–75% more likely to experience adverse drug reactions than men.

#MedicalBlindSpots #WomensHealth #MedicalFeminism #ClinicalTrials
Your joints and your gut are built from the same material.

Connective tissue holds your organs in position. When it’s built a little looser, they sit lower. The bowel slows. Food sits. Bacteria grow where they were never meant to.

That’s one road from hypermobility to a leaky gut lining.

The second runs through your nervous system, and most hypermobile people are traveling both at the same time.

It’s a big part of why a joint diagnosis turns into a list of conditions.

Comment READ and I’ll send you the full breakdown.
Adverse drug reactions cause over 100,000 deaths annually in the US and may represent the fourth leading cause of death. Roughly a third of drugs currently on the market are mitochondrial toxicants — toxic to the energy-producing machinery of cells — contributing to neuropathy, diabetes, brain fog, weight gain, and hormonal dysregulation. Dr. Hartman describes a common medication cascade: blood pressure drug → low potassium → palpitations → beta blocker → insulin resistance → diabetes → diabetes medication.

#MedicalBlindSpots #DrugReactions #MedicalError #FunctionalMedicine
Medical gaslighting isn't just something doctors do to patients. Sometimes it starts with us deciding our own symptoms are "probably nothing."

@drefratlamandre calls herself a recovering medical gaslighter after years of telling patients their labs looked fine. Then she became the patient, six months of back pain she talked herself out of investigating turned out to be stage 4 cancer.

If you've been told you're "fine" and walked out still knowing something's wrong, this one's for you. Full episode on YouTube.
Only roughly one third of primary care physicians currently feel capable of diagnosing long COVID — a condition affecting 10–30% of people who had COVID. The mechanism: the immune system remains pro-inflammatory instead of returning to baseline, producing brain fog, fatigue, gut issues, joint pain, and in some cases disabling dysautonomia. Dr. Hartman developed long COVID himself and knew how to treat it; most patients do not have that access.

#LongCOVID #MedicalBlindSpots #ChronicIllness #ImmuneHealth
His Lyme test came back negative. Then negative again. Then negative a third year running.

At year three it came back positive.

He didn’t catch Lyme in year three.

A Lyme antibody test never looks for the bacteria. It looks for your immune system’s response to them. If the immune system is depleted, there’s no response to find.

We spent three years working on his eosinophilic esophagitis and his SIBO. Once he had enough immune function to mount a response, the antibodies showed up.

The gut work got him from 60 to 80%. Treating the Lyme got him from 80 to 100%.

So that first negative result told us what his immune system could do that year. It never told us what was living in him.

Comment READ and I’ll send you the full article.
During the pandemic, physicians in some states lost their licenses for discussing long COVID. Dr. Hartman’s first long COVID patient was May 2020. Research suggests 10–30% of COVID patients develop the condition. Mechanisms include endothelial dysfunction, gut immune disruption, and reactivation of dormant infections such as Lyme and Epstein-Barr. Most university systems are tracking symptoms rather than treating underlying biology.

#LongCOVID #MedicalBlindSpots #ChronicIllness #FunctionalMedicine